ARTELO BIOSCIENCES, INC.
Profile
Company Names
ARTELO BIOSCIENCES, INC.
Addresses
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA 92075
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA 92075
888 PROSPECT STREET, SUITE 210, LA JOLLA, CA 92037
888 PROSPECT STREET, SUITE 210, LA JOLLA, CA 92037
Phone Numbers
858-925-7049
760-943-1689
760 943 1689
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
> 5 years ago
State Incorporated:
NEVADA
Total Amount Raised:
$33,246,326.00
Number of Funding Rounds:
13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2026-03-27
$10,996,903.00
$10,996,903.00
$0.00
Equity
12
2026-03-20
$315,000.00
$315,000.00
$0.00
Debt
11
2026-03-12
$237,300.00
$237,300.00
$0.00
Debt
10
2026-01-30
$500,000.00
$50,500,000.00
$50,000,000.00
Equity
9
2025-10-28
$3,718,121.00
$3,718,121.00
$0.00
Debt
8
2025-08-05
$9,475,000.00
$9,475,000.00
$0.00
Equity
7
2025-06-26
$1,425,000.00
$1,425,000.00
$0.00
Equity
6
2022-05-13
$96,972.00
$20,096,972.00
$20,000,000.00
Equity
5
2020-05-04
$55,000.00
$55,000.00
$0.00
Equity
4
2019-04-25
$857,430.00
$1,950,000.00
$1,092,570.00
Equity
3
2019-01-08
$4,192,990.00
$10,000,000.00
$5,807,010.00
Equity
2
2018-07-31
$525,824.00
$1,125,000.00
$599,176.00
Equity
1
2018-03-23
$850,786.00
$975,000.00
$124,214.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN
KELLY
DIRECTOR
PETER
O-BRIEN
EXECUTIVE OFFICER, DIRECTOR
MARK
SPRING
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-03-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2026-03-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2026-03-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2026-03-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-01-30
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2025-10-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-08-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-06-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-05-13
D
BIOTECHNOLOGY
SERVICES-BUSINESS SERVICES, NEC [7389]
DECLINE TO DISCLOSE
Equity
2020-05-04
D
OTHER HEALTH CARE
SERVICES-BUSINESS SERVICES, NEC [7389]
DECLINE TO DISCLOSE
Equity
2019-04-25
D
OTHER HEALTH CARE
SERVICES-BUSINESS SERVICES, NEC [7389]
DECLINE TO DISCLOSE
Equity
2019-01-08
D
OTHER HEALTH CARE
SERVICES-BUSINESS SERVICES, NEC [7389]
DECLINE TO DISCLOSE
Equity
2018-07-31
D
OTHER HEALTH CARE
SERVICES-BUSINESS SERVICES, NEC [7389]
DECLINE TO DISCLOSE
Equity
2018-03-23
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

